SCYNEXIS Stock

SCYNEXIS Net Change in Cash

The Net Change in Cash of SCYNEXIS (SCYX) as of Aug 14, 2026 is -18.00 M USD. In the previous year, Net Change in Cash was -11.44 M USD — a change of 57.34% (lower).

Net Change in Cash

-18.00 MUSD

YoY

57.34%

Last updated:

Net Change in Cash of SCYNEXIS is 2026 -18.00 M USD. Net Change in Cash of SCYNEXIS was 2025 -11.44 M USD. It decreases by 57.34% lower compared to the previous year.
Access this data via the Eulerpool API

SCYNEXIS Stock analysis

What does SCYNEXIS do? SCYNEXIS Inc is a biopharmaceutical company that focuses on the discovery and development of novel therapeutics for serious infectious diseases and cancer. The company was founded in 2000 and is headquartered in New Jersey, USA. SCYNEXIS is one of the most popular companies on Eulerpool.

Frequently Asked Questions about SCYNEXIS stock

Net Change in Cash of SCYNEXIS is -18.00 M USD in 2026.

Net Change in Cash of SCYNEXIS changed from -11.44 M USD to -18.00 M USD, representing a 57.34% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Net Change in Cash SCYNEXIS since 2006 – with annual values, charts, and detailed analysis.

Net change in cash is the total change in cash and equivalents during the period, combining operating, investing, and financing cash flows.

Net Change in Cash's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Net Change in Cash's SCYNEXIS historically and in real time.

Access this data via the Eulerpool API

Cash Flow — SCYNEXIS

All Key Metrics — SCYNEXIS